XML 76 R68.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity - Additional Information (Detail) (USD $)
In Millions, except Share data, unless otherwise specified
12 Months Ended 0 Months Ended 12 Months Ended
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2013
Minimum
Dec. 31, 2013
Maximum
Dec. 31, 2013
Unvested Stock Options
Dec. 31, 2012
Restricted Stock
Feb. 08, 2014
BOD authorized plan
Dec. 12, 2012
BOD authorized plan
Feb. 08, 2014
Rule 10b5-1 plan [Member]
Aug. 14, 2013
Rule 10b5-1 plan [Member]
Dec. 31, 2013
Employee Stock Purchase Plan
Dec. 31, 2013
Shareholder Rights Plan
Equity [Line Items]                          
Authorized amount under share repurchase program                 $ 50.0   $ 36.2    
Share repurchase plan commencement date                 Dec. 12, 2012   Aug. 14, 2013    
Share repurchase plan expiration date               Feb. 07, 2014   Feb. 07, 2014      
Term of plan, in years 10 years                        
Weighted average remaining contractual term option outstanding 3 years 11 months                        
Weighted average remaining contractual term option exercisable 2 years 5 months                        
Shares available for future grants 6,800,000 7,700,000 8,600,000                 500,000  
Total pre-tax intrinsic value of stock options exercised 1.8 6.7                      
Total pre-tax intrinsic value based on the closing stock price $ 11.59                        
Intrinsic value of stock options outstanding 6.7                        
Intrinsic value of stock options exercisable 4.8                        
Common shares reserved for future issuance under the ESPP 4,000,000                        
Percentage of employee contribution from compensation 10.00%                        
Rate of discount from the fair market value 15.00%                        
Shares issued under the ESPP 3,500,000                        
Shares purchase by employees 200,000 300,000 400,000                    
Weighted-average price per share paid by the employees $ 8.00 $ 7.34 $ 4.35                    
Weighted average remaining contractual term for unvested restricted shares, in years 2 years 1 year 10 months                      
Total compensation cost not yet recognized           $ 3.1 $ 9.8            
Compensation cost expected to be recognized (in years) 2 years 5 months                        
Share-based payment awards in the form of stock option awards 553,000 470,000 511,000                    
Vesting period, in years       3 years 4 years                
Contractual term of stock options (in years) 7 years                        
Shares entitled to be purchased of a series of preferred stock under each right                         one-hundredth
Exercise price under the shareholder rights plan                         $ 50
Redemption of rights                         $ 0.01
Percentage of common shares outstanding                         15.00%